4//SEC Filing
Clemmer James C 4
Accession 0001140361-24-035600
CIK 0001275187other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:53 PM ET
Size
9.1 KB
Accession
0001140361-24-035600
Insider Transaction Report
Form 4
Clemmer James C
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-07-17+56,279→ 690,312 total - Tax Payment
Common Stock
2024-07-17$7.40/sh−28,730$212,602→ 661,582 total - Exercise/Conversion
Performance Right
2024-07-17+52,378→ 0 total→ Common Stock (52,378 underlying)
Footnotes (3)
- [F1]This acquisition of 56,279 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021.
- [F2]The exempt disposition of 28,730 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021.
- [F3]On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001476700
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 9:53 PM ET
- Size
- 9.1 KB